From peer review to clinical trials

So there I was this morning talking about peer review, when what should come through the Ovarian Cancer Action letterbox but our certificate of best practice from the Association of Medical Research Charities (AMRC) for our peer reivew practices. It's great to have this 'quality-mark' for all that we do as a research funder. If … Continue reading From peer review to clinical trials

Some alternative thinking on peer review

A few years back I recommended an NIHR report for pool-side summer reading. Ever since I have been inundated with requests to make similar recommendations each year. A little like Greta Garbo I have refused. But not this year. RAND Europe - who are a little like the McKinsey of research proffering consultancy and advice … Continue reading Some alternative thinking on peer review

Public, private and charitable research: the spillover effect

RAND Europe and the Office of Health Economics (OHE) last week published this rather fascinating occasional paper from a seminar in May.  It examines the spillovers (wider benefits) from biomedical and health research and seems highly salient given what is going on.  I thought some of the diagrams were helpful in visualising the multilying effect of … Continue reading Public, private and charitable research: the spillover effect